Bodyport to Present First Real-World Heart Failure Monitoring Outcomes at THT 2026
November 9, 2025
AHA presentation demonstrating the complementary value of the Bodyport Congestion Index and PA pressure monitoring in heart failure patients
October 9, 2025
Low phase angle (PA) measured via the Bodyport Cardiac Scale is strongly associated with a higher risk of hospitalization in heart failure patients
September 26, 2024
Published Clinical Results Show Non-Invasive Monitoring Technology Predicts Heart Failure Events at Twice the Rate of Conventional Care
May 25, 2023
Study to Measure Accuracy of Unique Index for Early, Noninvasive Prediction of Worsening Heart Failure
August 9, 2022
Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale
August 2, 2022
Assessing Heart Function and Fluid Status with Cardiac Scales
June 23, 2022
Bodyport Announces Appointment of Jim Pursley to Board of Directors
June 23, 2022
Wearables are collecting a flood of data. An ambitious new study of pregnancy aims to prove that’s valuable for health
June 15, 2022
Bodyport Appoints John Lipman as Chief Executive Officer
April 8, 2022
Feasibility of a Cardiac Scale in Measuring Blood Pressure, Journal of Cardiovascular Translational Research, JCTR
March 8, 2022
Outpatient heart failure monitoring with a novel cardiac scale: tracking volume status, Journal of American College of Cardiology, JACC
December 7, 2021
Noninvasive Scale Measurement of Stroke Volume and Cardiac Output Compared With the Direct Fick Method: A Feasibility Study, Journal of American Heart Failure, JAHA
April 13, 2021
Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors
